Department of Medicine, Surgery and Dentistry, Università degli Studi di Milano, Milan, Italy.
Cancer Lett. 2011 Sep 1;308(1):1-13. doi: 10.1016/j.canlet.2011.05.009.
Notch receptors are transmembrane proteins critically determining cell fate and maintenance of progenitor cells in many developmental systems. Notch signaling is involved in stem cell self-renewal and regulates the main functions of cell life at different levels of development: cell proliferation, differentiation and apoptosis. By virtue of its involvement in the regulation of cell physiology, it is not surprising that a deregulation of the Notch pathway leads to the development of different tumors. In this review, we critically discuss the latest findings concerning Notch roles in hematologic oncology, with a special focus on T-cell acute lymphoblastic leukemia and B-cell malignancies. We also describe the molecular mediators of Notch-driven oncogenic effects and the current pharmacological approaches targeting Notch signaling.
Notch 受体是跨膜蛋白,在许多发育系统中对细胞命运和祖细胞的维持具有关键作用。Notch 信号通路参与干细胞自我更新,并在不同发育水平上调节细胞生命的主要功能:细胞增殖、分化和凋亡。由于其参与细胞生理学的调节, Notch 途径的失调导致不同肿瘤的发生并不奇怪。在这篇综述中,我们批判性地讨论了 Notch 在血液肿瘤学中的最新发现,特别关注 T 细胞急性淋巴细胞白血病和 B 细胞恶性肿瘤。我们还描述了 Notch 驱动的致癌效应的分子介质和目前针对 Notch 信号的药理学方法。